Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Direct Oral Anticoagulants as the First Choice of Anticoagulation for Patients with Peripheral Artery Disease to Prevent Adverse Vascular Events: A Systematic Review and Meta-Analysis.
Pomozi E, Nagy R, Fehérvári P, Hegyi P, Kiss B, Dembrovszky F, Kosztin A, Nardai S, Zima E, Szeberin Z. Pomozi E, et al. Among authors: kosztin a. J Cardiovasc Dev Dis. 2023 Feb 3;10(2):65. doi: 10.3390/jcdd10020065. J Cardiovasc Dev Dis. 2023. PMID: 36826561 Free PMC article. Review.
Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience.
Kutyifa V, Geller L, Bogyi P, Zima E, Aktas MK, Ozcan EE, Becker D, Nagy VK, Kosztin A, Szilagyi S, Merkely B. Kutyifa V, et al. Among authors: kosztin a. Eur J Heart Fail. 2014 Dec;16(12):1323-30. doi: 10.1002/ejhf.185. Epub 2014 Nov 7. Eur J Heart Fail. 2014. PMID: 25379962 Free PMC article.
Complement C3a predicts outcome in cardiac resynchronization therapy of heart failure.
Széplaki G, Boros AM, Szilágyi S, Osztheimer I, Jenei Z, Kosztin A, Nagy KV, Karády J, Molnár L, Tahin T, Zima E, Gellér L, Prohászka Z, Merkely B. Széplaki G, et al. Among authors: kosztin a. Inflamm Res. 2016 Dec;65(12):933-940. doi: 10.1007/s00011-016-0976-4. Epub 2016 Aug 4. Inflamm Res. 2016. PMID: 27492980
Quality of life measured with EuroQol-five dimensions questionnaire predicts long-term mortality, response, and reverse remodelling in cardiac resynchronization therapy patients.
Nagy KV, Széplaki G, Perge P, Boros AM, Kosztin A, Apor A, Molnár L, Szilágyi S, Tahin T, Zima E, Kutyifa V, Gellér L, Merkely B. Nagy KV, et al. Among authors: kosztin a. Europace. 2018 Sep 1;20(9):1506-1512. doi: 10.1093/europace/eux342. Europace. 2018. PMID: 29182734 Free PMC article.
Long-term survival following upgrade compared with de novo cardiac resynchronization therapy implantation: a single-centre, high-volume experience.
Schwertner WR, Behon A, Merkel ED, Tokodi M, Kovács A, Zima E, Osztheimer I, Molnár L, Király Á, Papp R, Gellér L, Kuthi L, Veres B, Kosztin A, Merkely B. Schwertner WR, et al. Among authors: kosztin a. Europace. 2021 Aug 6;23(8):1310-1318. doi: 10.1093/europace/euab059. Europace. 2021. PMID: 34037220 Free PMC article.
59 results